查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1530033

乳房病變定位市場規模、佔有率、趨勢分析報告：按類型、地區、細分市場預測，2024-2030 年

Breast Lesion Localization Methods Market Size, Share & Trends Analysis Report By Type (Wire Guided Localization, Radioisotope Localization, Magnetic Tracer, & Others), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

乳房病變定位市場成長與趨勢：

Grand View Research, Inc.最新報告預測，到2030年，全球乳房病變定位市場規模預計將達到36.2億美元，2024年至2030年複合年成長率為7.8%。預計政府和非政府對乳癌診斷、切片檢查、測試和相關醫療程序的報銷政策的增加將推動乳房病變定位方法的採用。此外，由於女性乳癌發病率上升，對改善醫療基礎設施和設施的需求不斷成長，預計將推動市場成長。

隨著女性乳癌發生率的增加，對準確、早期檢測方法的需求也隨之增加。乳房病變定位技術對於準確識別可疑病變並針對其進行切片檢查或手術干預至關重要。例如，根據美國國家乳癌基金會2024年4月的報告，美國八分之一的女性在一生中將被診斷出罹患乳癌。到 2024 年，預計將有約 310,720 名女性和 2,800 名男性被診斷出患有侵襲性乳癌。乳癌盛行率的增加引起了人們對客製化治療策略的關注。先進的病灶定位技術可以幫助腫瘤科醫師和外科醫師制定和實施詳細的治療計劃，為患者實現最佳結果。這些因素推動了對乳房病變定位方法的需求。

數位乳房X光攝影、超音波和MRI等影像技術的進步極大地改善了乳房病變的檢測和表徵。因此，對精確定位技術來準確指導外科手術的需求日益成長。此外，3D顯像模式和導航系統的整合使外科醫生能夠在手術過程中即時可視化乳房病變的位置，從而顯著提高手術準確性並改善患者的治療效果。這些因素正在推動預測期內的市場成長。

乳房病變定位市場報告亮點：

  • 按產品類型分類，由於產品種類繁多且最終用戶對該技術的採用率很高，因此到 2023 年，線導立體定位技術將佔據最大的市場佔有率。
  • 基於放射性同位素的乳房定位預計在預測期內將出現顯著成長，因為它有效、安全且廣泛用於術前定位不可觸及的可疑乳房病變。
  • 由於該地區主要製造商的存在、成熟的醫療基礎設施以及引進本地化設備的進展，北美地區將在 2023 年擁有最高的銷售佔有率並主導市場。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章乳房病變定位方法的市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 乳房病灶定位方法市場分析工具
    • 波特五力分析
    • PESTEL分析

第4章乳房病變定位市場：按類型估計和趨勢分析

  • 細分儀表板
  • 全球乳房病變定位方法市場：類型變異分析，百萬美元，數量單位，2023 年和 2030 年
  • 2018-2030年全球乳房病變定位方法市場規模及趨勢分析（依類型）
  • 找到導線器
  • 放射性同位素定位
  • 磁示踪劑
  • 其他

第5章乳房病變定位市場：區域、估計與趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第6章 競爭狀況

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 2023 年企業市場佔有率分析
  • 企業熱力圖分析
  • 策略規劃
    • 擴張
    • 併購
    • 夥伴關係與協作
    • 新產品發布
    • 研究與開發
    • 公司簡介
    • BD
    • SOMATEX Medical Technologies GmbH
    • Argon Medical Devices
    • Merit Medical Systems
    • Cook Medical
    • STERYLAB Srl
    • Theragenics Corporation
    • MDL SRL
    • MOLLI Surgical
    • Mermaid Medical
    • IsoAid
    • Intramedical Imaging, LLC
Product Code: GVR-1-68038-958-6

Breast Lesion Localization Methods Market Growth & Trends:

The global breast lesion localization methods market size is anticipated to reach USD 3.62 billion by 2030 and is anticipated to grow at a CAGR of 7.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing government and non-government reimbursement policies for breast cancer diagnostics, biopsies, examinations, and related medical procedures are projected to drive adoption of breast lesion localization methods. Furthermore, the growing demand for improved healthcare infrastructure and facilities, driven by the rising prevalence of the disease among women, is anticipated to boost the market growth.

As the incidence of breast cancer among women rises, there is a heightened need for precise and early detection methods. Breast lesion localization techniques are pivotal in accurately identifying and targeting suspicious lesions for biopsy or surgical intervention. For instance, As per a report by National Breast Cancer Foundation, Inc., in April 2024, approximately 1 out of every 8 women in the U.S. will receive a breast cancer diagnosis during her lifetime. In 2024, it is projected that around 310,720 women and 2,800 men will be diagnosed with invasive breast cancer. With the increasing prevalence of breast cancer, there is a growing focus on tailored treatment strategies. Advanced lesion localization methods empower oncologists and surgeons to meticulously plan and deliver treatments, aiming for the best possible patient outcomes. These factors are driving the demand for breast lesions localizations methods.

Advancements in imaging technologies like digital mammography, ultrasound, and MRI have greatly improved the detection and characterization of breast lesions. As a result, there is an increased need for precise localization techniques to guide surgical procedures accurately. Furthermore, the integration of 3D imaging modalities and navigation systems allows surgeons to visualize breast lesion locations in real-time during procedures, significantly enhancing surgical precision and improving patient outcomes. These factors are propelling the market growth over the forecast period.

Breast Lesion Localization Methods Market Report Highlights:

  • Based on type, the wire-guided localization segment held the largest market share in 2023 owing to the presence of a wide range of products and high adoption of this technique among end-users.
  • Radioisotope localization is expected to witness significant growth over the forecast period as it is an effective, safe, and widely used procedure for preoperative localization of non-palpable, suspicious breast lesions.
  • North America dominated the market with the highest revenue share in 2023 owing to the presence of key manufacturers in the region, established healthcare infrastructure, and high adoption of localization devices.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Breast Lesion Localization Methods Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising prevalence of breast cancer among women
      • 3.2.1.2. Increasing awareness through cancer screening programs
      • 3.2.1.3. Technological advancements
      • 3.2.1.4. Availability of various techniques
      • 3.2.1.5. Demand for minimally invasive and accurate procedures
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Risk associated with breast localization methods
      • 3.2.2.2. Presence of complicated regulatory framework
  • 3.3. Breast Lesion Localization Methods Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Breast Lesion Localization Methods Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Breast Lesion Localization Methods Market: Type Movement Analysis, USD Million, Volume Unit, 2023 & 2030
  • 4.3. Global Breast Lesion Localization Methods Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million, Volume Unit,)
  • 4.4. Wire Guided Localization
    • 4.4.1. Wire guided localization market revenue estimates and forecasts, 2018 - 2030 (USD Million, Volume Unit)
  • 4.5. Radioisotope Localization
    • 4.5.1. Radioisotope localization market revenue estimates and forecasts, 2018 - 2030 (USD million)
    • 4.5.2. Radio guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
      • 4.5.2.1. Radio Guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
    • 4.5.3. Radio guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
      • 4.5.3.1. Radio Guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
    • 4.5.4. Radioactive-seed localization (RSL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
      • 4.5.4.1. Radioactive-seed localization (RSL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
    • 4.5.5. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
      • 4.5.5.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.6. Magnetic Tracer
    • 4.6.1. Magnetic tracer market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.7. Others
    • 4.7.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million, Volume Unit)

Chapter 5. Breast Lesion Localization Methods Market: Regional Estimates & Trend Analysis by Type

  • 5.1. Regional Dashboard
  • 5.2. Market Size and Trend Analysis, 2018 to 2030
  • 5.3. North America
    • 5.3.1. North America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Competitive scenario
      • 5.3.2.3. Regulatory framework
      • 5.3.2.4. Reimbursement scenario
      • 5.3.2.5. U.S. breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Competitive scenario
      • 5.3.3.3. Regulatory framework
      • 5.3.3.4. Reimbursement scenario
      • 5.3.3.5. Canada breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key country dynamics
      • 5.3.4.2. Competitive scenario
      • 5.3.4.3. Regulatory framework
      • 5.3.4.4. Reimbursement scenario
      • 5.3.4.5. Mexico breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Competitive scenario
      • 5.4.2.3. Regulatory framework
      • 5.4.2.4. Reimbursement scenario
      • 5.4.2.5. UK breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Competitive scenario
      • 5.4.3.3. Regulatory framework
      • 5.4.3.4. Reimbursement scenario
      • 5.4.3.5. Germany breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Competitive scenario
      • 5.4.4.3. Regulatory framework
      • 5.4.4.4. Reimbursement scenario
      • 5.4.4.5. France breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Competitive scenario
      • 5.4.5.3. Regulatory framework
      • 5.4.5.4. Reimbursement scenario
      • 5.4.5.5. Italy breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Competitive scenario
      • 5.4.6.3. Regulatory framework
      • 5.4.6.4. Reimbursement scenario
      • 5.4.6.5. Spain breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Competitive scenario
      • 5.4.7.3. Regulatory framework
      • 5.4.7.4. Reimbursement scenario
      • 5.4.7.5. Sweden breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Competitive scenario
      • 5.4.8.3. Regulatory framework
      • 5.4.8.4. Reimbursement scenario
      • 5.4.8.5. Denmark breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.9. Norway
      • 5.4.9.1. Key country dynamics
      • 5.4.9.2. Competitive scenario
      • 5.4.9.3. Regulatory framework
      • 5.4.9.4. Reimbursement scenario
      • 5.4.9.5. Norway breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Competitive scenario
      • 5.5.2.3. Regulatory framework
      • 5.5.2.4. Reimbursement scenario
      • 5.5.2.5. China breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Japan
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Competitive scenario
      • 5.5.3.3. Regulatory framework
      • 5.5.3.4. Reimbursement scenario
      • 5.5.3.5. Japan breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Competitive scenario
      • 5.5.4.3. Regulatory framework
      • 5.5.4.4. Reimbursement scenario
      • 5.5.4.5. India breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Competitive scenario
      • 5.5.5.3. Regulatory framework
      • 5.5.5.4. Reimbursement scenario
      • 5.5.5.5. South Korea breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Australia
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Competitive scenario
      • 5.5.6.3. Regulatory framework
      • 5.5.6.4. Reimbursement scenario
      • 5.5.6.5. Australia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Thailand
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Competitive scenario
      • 5.5.7.3. Regulatory framework
      • 5.5.7.4. Reimbursement scenario
      • 5.5.7.5. Thailand breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Competitive scenario
      • 5.6.2.3. Regulatory framework
      • 5.6.2.4. Reimbursement scenario
      • 5.6.2.5. Brazil breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Competitive scenario
      • 5.6.3.3. Regulatory framework
      • 5.6.3.4. Reimbursement scenario
      • 5.6.3.5. Argentina breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Middle East and Africa
    • 5.7.1. Middle East and Africa breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Competitive scenario
      • 5.7.2.3. Regulatory framework
      • 5.7.2.4. Reimbursement scenario
      • 5.7.2.5. South Africa breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Competitive scenario
      • 5.7.3.3. Regulatory framework
      • 5.7.3.4. Reimbursement scenario
      • 5.7.3.5. Saudi Arabia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Competitive scenario
      • 5.7.4.3. Regulatory framework
      • 5.7.4.4. Reimbursement scenario
      • 5.7.4.5. UAE breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Competitive scenario
      • 5.7.5.3. Regulatory framework
      • 5.7.5.4. Reimbursement scenario
      • 5.7.5.5. Kuwait breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Market Share Analysis, 2023
  • 6.4. Company Heat Map Analysis
  • 6.5. Strategy Mapping
    • 6.5.1. Expansion
    • 6.5.2. Mergers & Acquisition
    • 6.5.3. Partnerships & Collaborations
    • 6.5.4. New Product Launches
    • 6.5.5. Research And Development
    • 6.5.6. Company Profiles
    • 6.5.7. BD
      • 6.5.7.1. Company overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product Benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. SOMATEX Medical Technologies GmbH
      • 6.5.8.1. Company overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product Benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. Argon Medical Devices
      • 6.5.9.1. Company overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product Benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Merit Medical Systems
      • 6.5.10.1. Company overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product Benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Cook Medical
      • 6.5.11.1. Company overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product Benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. STERYLAB S.r.l.
      • 6.5.12.1. Company overview
      • 6.5.12.2. Financial performance
      • 6.5.12.3. Product Benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. Theragenics Corporation
      • 6.5.13.1. Company overview
      • 6.5.13.2. Financial performance
      • 6.5.13.3. Product Benchmarking
      • 6.5.13.4. Strategic initiatives
    • 6.5.14. MDL SRL
      • 6.5.14.1. Company overview
      • 6.5.14.2. Financial performance
      • 6.5.14.3. Product Benchmarking
      • 6.5.14.4. Strategic initiatives
    • 6.5.15. MOLLI Surgical
      • 6.5.15.1. Company overview
      • 6.5.15.2. Financial performance
      • 6.5.15.3. Product Benchmarking
      • 6.5.15.4. Strategic initiatives
    • 6.5.16. Mermaid Medical
      • 6.5.16.1. Company overview
      • 6.5.16.2. Financial performance
      • 6.5.16.3. Product Benchmarking
      • 6.5.16.4. Strategic initiatives
    • 6.5.17. IsoAid
      • 6.5.17.1. Company overview
      • 6.5.17.2. Financial performance
      • 6.5.17.3. Product Benchmarking
      • 6.5.17.4. Strategic initiatives
    • 6.5.18. Intramedical Imaging, LLC
      • 6.5.18.1. Company overview
      • 6.5.18.2. Financial performance
      • 6.5.18.3. Product Benchmarking
      • 6.5.18.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 4 U.S. breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 5 Canada breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 6 Mexico breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 7 Europe breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
  • Table 8 Europe breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 9 Germany breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 10 UK breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 11 lesion localization methods market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 France breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 13 Italy breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 14 Spain breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 15 Denmark breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 16 Sweden breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 17 Norway breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 20 China breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 21 Japan breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 22 India breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 23 South Korea breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 24 Australia breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 25 Thailand breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 26 Latin America breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
  • Table 27 Latin America breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 28 Brazil breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 29 Argentina breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 30 MEA breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
  • Table 31 MEA breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 32 South Africa breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 33 Saudi Arabia breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 34 UAE breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 35 Kuwait breast lesion localization methods market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Breast lesion localization methods market segmentation.
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing.
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot.
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Breast lesion localization methods - market size and growth prospects (USD Million)
  • Fig. 11 Breast lesion localization methods market: Industry Value Chain Analysis
  • Fig. 12 Breast lesion localization methods market: Market Dynamics
  • Fig. 13 Breast lesion localization methods market: PORTER's Five Forces Analysis
  • Fig. 14 Breast lesion localization methods market: PESTEL Analysis
  • Fig. 15 Breast lesion localization methods market share by type, 2023 & 2030 (USD Million)
  • Fig. 16 Breast lesion localization methods market, by type: market share, 2023 & 2030.
  • Fig. 17 Wire guided localization market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 18 Radioisotope localization market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 19 Radio guided occult-lesion localization (ROLL) market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 20 Radioactive-seed localization (RSL) market estimates & forecasts, 2018 - 2030 (Revenue, USD Million, Volume Unit)
  • Fig. 21 Others market estimates & forecasts, 2018 - 2030 (Revenue, USD Million, Volume Unit)
  • Fig. 22 Magnetic tracer market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 23 Others market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 24 Regional marketplace: key takeaways
  • Fig. 25 North America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Canada breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Europe breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 UK breast lesion localization methods market estimates and forecasts, 2018 - 2030,) (USD Million)
  • Fig. 31 Germany breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 France breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Italy breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Spain breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Denmark breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Norway breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Breast Lesion Localization Methods Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 39 China breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Japan breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 India breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Australia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 MEA breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UAE breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key company categorization
  • Fig. 54 Company market positioning
  • Fig. 55 Key company market share analysis, 2023
  • Fig. 56 Strategic framework